Table 2.
Clinical characteristics of patients | Number of studies n (%) |
|
---|---|---|
Main diagnostic motivating PC | Only cancer | 25 (58.14) |
Cancer and other terminal conditions | 18 (41.86) | |
CHFa | 12 (27.91)b | |
COPDa | 12 (27.91)b | |
Dementia/ADa | 7 (16.28)b | |
Disease severity specified | Yes | 16 (37.21) |
No | 12 (27.91) | |
Non-specified/no data | 15 (34.88) | |
Comorbidity associated | Yesc | 11 (25.58) |
No | 11 (25.58) | |
Non specified/no data | 21 (48.84) | |
Study time frame (follow-up periods) | Until 1 month | 10 (23.26) |
1≤×≤6 months | 8 (18.60) | |
6<×≤12 months | 10 (23.26) | |
>12 months | 7 (16.28) | |
Several periodsd | 7 (16.28) | |
No data | 1 (2.33) | |
Survival data of patients (from PC beginning) | ||
Mean survival, days (SD) | 279.52 (455.01) | 12 (30) |
Median survival, days (range) | 143.82 (42–330) | 7 (16.28) |
Sociodemographic characteristics of patients | ||
Age, years (mean [SD]) | (71.42 [7.53]) | 32 (74.56) |
Women (% [SD]) | (46.97 [10.64]) | 39 (90.70) |
Marital status reported | 15 (35.71) | |
Ethnicity | 9 (20.93) | |
Education level reported | 6 (13.95) | |
Sociodemographic characteristics of caregivers | ||
Age, years (mean [SD]) | (57.83 [2.02]) | 8 (18.64) |
Women (% [SD]) | (70.13 [5.62]) | 10 (23.3) |
Marital status reported | 5 (11.90) | |
Ethnicity | – | |
Education level reported | 1 (2.33) |
aCHF: Chronic Heart Failure; COPD: Chronic Obstructive Pulmonary Disease; AD: Alzheimer’s Disease
bPercentage out of a total of 43 studies
cOut of 11 reported, the Charlson Comorbidity Index was used in 4 (36.36%)
dData were collected in several periods for a repeated-measures analysis